Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
4.44
Oct 30 • 3:59 PM ET Dollar change-0.31 Percentage change(-6.53%)
Aftermarket Close
4.40
Aftermarket • 7:46 PM ET Dollar change-0.04 Percentage change(-0.90%)
Index
RUT
Market Cap
392.79M
Enterprise Value
374.02M
Income
-16.43M
Sales
255.97M
Book/sh
3.16
Cash/sh
0.26
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
601
IPO
Nov 05, 2019
P/E
-
Forward P/E
1333.33
PEG
-
P/S
1.53
P/B
1.41
P/C
17.06
P/FCF
-
EV/EBITDA
45.28
EV/Sales
1.46
Quick Ratio
2.64
Current Ratio
2.64
Debt/Eq
0.02
LT Debt/Eq
0.01
Option/Short
Yes / Yes
EPS (ttm)
-0.19
EPS next Y
0.00
EPS next Q
-0.01
EPS this Y
63.39%
EPS next Y
103.60%
EPS next 5Y
-
EPS past 3/5Y
20.73% 20.42%
Sales past 3/5Y
10.50% -
EPS Y/Y TTM
19.57%
Sales Y/Y TTM
0.64%
EPS Q/Q
-165.22%
Sales Q/Q
2.41%
Insider Own
24.36%
Insider Trans
-0.65%
Inst Own
59.62%
Inst Trans
-2.96%
ROA
-7.84%
ROE
-9.22%
ROIC
-5.82%
Gross Margin
16.67%
Oper. Margin
-3.04%
Profit Margin
-6.42%
SMA20
-3.64%
SMA50
-13.02%
SMA200
-12.91%
Trades
Shs Outstand
88.47M
Shs Float
66.92M
52W High
6.50 -31.69%
52W Low
3.95 12.41%
Volatility
4.06% 3.68%
ATR (14)
0.19
RSI (14)
36.42
Beta
2.55
Rel Volume
1.20
Avg Volume
920.85K
Volume
1,109,439
Perf Week
-4.72%
Perf Month
-8.07%
Perf Quarter
-20.00%
Perf Half Y
-12.60%
Perf YTD
-7.69%
Perf Year
-12.77%
Perf 3Y
101.82%
Perf 5Y
-53.12%
Perf 10Y
-
Prev Close
4.75
Price
4.44
Change %
-6.53%
Consensus
Strong Buy
Avg. Price Target
$9.56
Implied Upside
+115.3%
Analysts9incl. previous ratings
Rating Distribution9 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Mar 25, 2026Initiated
CCraig Hallum
Buy$8+80.2%
Mar 25, 2026Initiated
RILY logoRB. Riley Securities
Buy$8+80.2%
Dec 02, 2025Resumed
LLake Street
Buy$8+80.2%
Feb 26, 2025Initiated
LLake Street
Buy$6.50+46.4%
Jul 18, 2023Initiated
LLadenburg Thalmann
Buy$13+192.8%
Jul 17, 2023Initiated
LLadenburg Thalmann
Buy$13+192.8%
Sep 28, 2021Initiated
OPY logoOOppenheimer
Outperform$14+215.3%
Sep 09, 2021Initiated
JPM logoJJP Morgan
Overweight$16+260.4%
Sep 01, 2021Initiated
DB logoDDeutsche Bank
Buy$15+237.8%
Aug 26, 2021Initiated
CCredit Suisse
Outperform$14+215.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
The Eric L. Affeldt Living TruFormer BoardmemberOct 02 '26Proposed Sale5.17100,000517,000Oct 02 12:18 PM
Love ReginaldDirectorAug 10 '26Sale5.755,09129,273146,481Aug 13 05:33 PM
Heyburn William A.Co-CEO and CFOJun 08 '26Sale5.8731,671185,9091,548,997Jun 10 04:06 PM
Cohen AmirChief Accounting OfficerJun 08 '26Sale5.874,65527,325146,608Jun 10 04:06 PM
Tomkiel Melissa M.Co-CEO and General CounselJun 08 '26Sale5.8729,730174,5151,892,774Jun 10 04:05 PM
Wunsch Scott MCEO, LogisticsJun 08 '26Sale5.875,55032,578625,574Jun 10 04:05 PM
Cohen AmirChief Accounting OfficerMay 22 '26Sale5.9140,575239,798151,263May 26 04:49 PM
Cohen AmirChief Accounting OfficerMay 21 '26Sale5.7910,30059,637191,838May 26 04:49 PM
Cohen AmirChief Accounting OfficerMay 11 '26Sale5.7914,30682,832202,138May 13 04:04 PM
AMIR COHENOfficerMay 11 '26Proposed Sale5.5765,181363,058May 11 04:38 PM
Tomkiel Melissa M.Co-CEO and General CounselJan 02 '26Option Exercise0.18276,96049,8531,643,362Jan 05 04:22 PM
Heyburn William A.Co-CEO and CFODec 09 '25Buy4.4717,00076,0441,403,436Dec 10 04:15 PM
LAUCK ANDREWDirectorDec 05 '25Buy4.375,00021,825135,642Dec 05 04:21 PM
Love ReginaldDirectorNov 20 '25Sale4.3711,00048,070113,897Nov 24 04:23 PM
Love ReginaldDirectorNov 19 '25Sale4.3111,00047,434124,897Nov 20 04:07 PM
Reginald Lamonte LoveDirectorNov 20 '25Proposed Sale4.3711,00048,070Nov 20 04:05 PM
Reginald Lamonte LoveDirectorNov 19 '25Proposed Sale4.3111,00047,433Nov 19 05:07 PM
Tomkiel Melissa M.Co-CEO and General CounselNov 07 '25Option Exercise0.1827,7785,0001,400,420Nov 12 04:20 PM
Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the United States healthcare industry. It operates through the following segments: Logistics and Clinical. The Logistics segment includes Organ Placement, Air, and Ground Logistics. The Clinical segment focuses on Organ Recovery, Normothermic Regional Perfusion, Preservation, and Cardiac Care. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY.
Co- CEOMs. Melissa M. Tomkiel J.D.
Co-CEOMr. William A. Heyburn
Chief Accounting & Integration OfficerMr. Amir M. Cohen
Chief Executive Officer of Logistics ServicesMr. Scott M. Wunsch
CFO of Clinical Services & VP of Finance and Investor RelationsMr. Mathew Schneider C.F.A.